LA-BLA,* nM | BLA-CeA, nM | VAP-CeA, nM | |
---|---|---|---|
LCCG1 | |||
Control/implanted | 36 | 65.8 | 157.6 |
Kindled | 1.2 | 32.8 | 13.9 |
LCCG1 | |||
Control/saline | 57.8 | 719 | |
Chronic cocaine | (NE) | (NE) | |
LY354740 | |||
Control/saline | 2.1 | 27.7 | |
Chronic cocaine | (NE) | (NE) | |
LAP4 | |||
Control/implanted | 297 | 54.8 | 17.6 |
Kindled | 10.8 | 1.1 | 3.7 |
LAP4 | |||
Control/saline | 80.7 | 15.3 | |
Chronic cocaine | (NE) | (NE) |
-
↵* Data from Neugebauer et al. (1997). NE, no effect; LA, lateral amygdala; mGluR, metabotropic glutamate receptor; LCCG1, (2S,1′S,2′S)-2-(carboxycyclopropyl)glycine; LY354740, (+)-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid; LAP4, L(+)-2-amino-4-phosphonobutyrate.